Table 2.
Reference | Patient (n) | AL, n (%) | PC, n (%) | Ch, n (%) | ICUS (d) | HS (d) | 30-DM | Mortality, n (%) | FP (m) |
---|---|---|---|---|---|---|---|---|---|
Liu et al9 | 20 | 0 | 0 | 0 | NA | 19 | NA | NA | 11.5 |
Li et al14 | 6 | 0 | NA | NA | 0 | 17 | NA | NA | 2.5 |
Li et al15 | 6 | 0 | 0 | 0 | NA | NA | NA | NA | NA |
Du et al16 | 45 | NA | NA | NA | NA | 10.0 ± 1.0 | NA | NA | NA |
Liu et al17 | 98 | 2 (2.0) | 10 (10.2) | 3 (3.1) | NA | 12.7 ± 3.5 | 1 | NA | NA |
Hou et al18 | 41 | 1 (2.4) | 2 (4.9) | 0 | NA | NA | NA | NA | 15.7 |
41 | 1 (2.4) | 1 (2.4) | 2 (4.9) | NA | NA | NA | NA | 16.3 | |
Wu et al20 | 32 | 3 (9.4) | 1 (3.1) | 1 (3.1) | 2.2 | 11.6 | NA | NA | NA |
8 | 1 (12.5) | 0 | 0 | 1.2 | 10.6 | NA | NA | NA | |
Zhou et al22 | 30 | 2 (6.7) | 2 (6.7) | 1 (3.3) | NA | 11.7 ± 6.3 | 0 | 0 | NA |
Tan et al23 | 36 | 5 (13.9) | 1 (2.8) | 1 (2.8) | NA | 8.7 | 0 | 0 | NA |
Wang et al24 | 27 | 5 (18.5) | 1 (3.7) | 2 (7.4) | 2.3 ± 1.7 | NA | NA | NA | NA |
Feng et al25 | 27 | 5 (18.5) | 7 (25.9) | 0 | 3.1 ± 4.4 | 11.1 ± 6.6 | 1 | NA | 36 |
27 | 4 (14.8) | 4 (14.8) | 1 (3.7) | 1.9 ± 4.2 | 13.3 ± 10.6 | 0 | NA | 36 | |
Wang et al26 | 48 | 10 (20.8) | 2 (4.2) | 1 (2.1) | 2.5 ± 1.7 | NA | 0 | NA | NA |
49 | 3 (6.1) | 6 (12.2) | 1 (2.0) | 2.8 ± 1.9 | NA | 0 | NA | NA | |
Feng et al27 | 52 | 8 (15.4) | 5 (9.6) | 2 (3.8) | 1.3 ± 3.5 | 13.6 ± 9.3 | NA | NA | NA |
36 | 2 (5.6) | 1 (2.8) | 0 | 1.1 ± 1.5 | 10.9 ± 6.0 | NA | NA | NA | |
Shen et al28 | 76 | 16 (21.1) | 5 (6.6) | 1 (1.3) | NA | 19.2 ± 16.3 | NA | 0 | NA |
Feng et al29 | 41 | 9 (22.0) | 4 (9.8) | NA | 3.5 ± 1.3 | 17.4 ± 12.5 | NA | NA | NA |
52 | 4 (7.7) | 5 (9.6) | NA | 1.5 ± 1.1 | 11.4 ± 6.8 | NA | NA | NA | |
Wang et al30 | 260 | 26 (10) | 22 (8.5) | 3 (1.2) | NA | 14.3 ± 7.5 | NA | 2 (7.7) | NA |
Zhu et al31 | 25 | 1 (4) | NA | NA | NA | 10.9 ± 2.5 | NA | NA | NA |
Chen et al32 | 67 | NA | 7 (10.4) | NA | NA | 11.5 ± 1.6 | NA | NA | 14.0 ± 2.2 |
Zhu et al33 | 11 | 2 (18.2) | 3 (27.3) | NA | NA | 18.9 ± 10.3 | NA | NA | 4.5 |
Lin et al34 | 80 | 1 (1.3) | NA | 2 (2.5) | NA | NA | NA | NA | NA |
Liu et al35 | 297 | 9 (3.0) | 41 (18.8) | NA | NA | 17.4 ± 9.8 | NA | NA | NA |
Lin et al36 | 150 | 9 (6.0) | 17 (11.3) | 5 (3.3) | NA | NA | 2 (1.3) | 9 (6) | 3–22 |
Cense et al38 | 30 | 1 (3.3) | 12 (40) | NA | NA | NA | NA | NA | NA |
27 | 1 (3.7) | 13 (48.1) | NA | NA | NA | NA | 2 (7) | NA | |
Law et al39 | 30 | 1 (3.3) | 12 (40) | 0 | NA | NA | 1 | NA | NA |
Wong et al40 | 12 | 1 (8.3) | 2 (17) | NA | 2 | 41 | 0 | 0 | NA |
Wang et al41 | 33 | 1 (3.0) | 0 | 0 | NA | NA | NA | NA | NA |
Xie et al42 | 100 | 11 (11) | 13 (13) | 3 (3) | 1 (1) | 12 (12) | NA | NA | NA |
Yuan et al43 | 32 | 2 (6.3) | NA | NA | 1 | 11.1 ± 1.3 | 0 | NA | NA |
36 | 5 (13.9) | NA | NA | 1 | 11.6 ± 1.7 | 0 | NA | NA | |
Guo et al44 | 89 | 6 (6.7) | 4 (4.5) | 4 (4.5) | NA | 15.2 ± 9.8 | NA | NA | NA |
Guo et al45 | 135 | 9 (6.7) | 7 (5.2) | 8 (5.9) | NA | NA | NA | NA | NA |
Zhang et al46 | 160 | 21 (13.1) | 25 (15.6) | 4 (2.5) | 1 | 13.1 | 2 (1.3) | 4 (2.5) | NA |
Gao et al48 | 96 | 7 (7.3) | 13 (13.5) | 1 (1.1) | 19.2 ± 3.5 | 12.6 ± 8.8 | NA | 2 (2.1) | NA |
Abbreviations: AL, anastomotic leaks; PC, pulmonary complication; Ch, chylothorax; ICUS (d), intensive care unit stay (days); HS (d), hospital stay (days); 30-DM, 30-day mortality; FP (m), follow-up period (months); NA, not available.